Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.020
+0.020 (2.00%)
At close: Oct 9, 2026, 4:00 PM EDT
1.074
+0.054 (5.29%)
After-hours: Oct 9, 2026, 7:16 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $63.16 million as of October 9, 2026. It is the 28,756th most valuable company in the world and the 4,495th biggest in the United States. Its market cap has decreased by 32.75% in one year.
Market Cap
63.16M
Enterprise Value
-66.20M
1-Year Change
-32.75%
Global Rank
Country Rank
#4,495 United States
Category
ChartMarket Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $63.16M, a decrease of -91.44%. That is a compound annual growth rate of -32.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 63.16M | -15.75% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 62.76M |
| Adicet Bio | 61.79M |
| Alps Group | 61.45M |
| Eloxx Pharmaceuticals | 61.27M |
| Gossamer Bio | 60.37M |
| RenovoRx | 60.02M |
| Mereo BioPharma Group | 59.92M |
| Xilio Therapeutics | 59.29M |